Ovid Therapeutics OVID
NASDAQ OVID
$2.47 +0.11 (+4.66%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) EV to EBITDA (2021)

Updated

Ovid Therapeutics' EV to EBITDA came in at 0.31 for Q4 2021, up 47.9% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) EV to EBITDA (2021) Analysis & Trends

Going back to Q1 2021, Ovid Therapeutics' EV to EBITDA data covers 4 quarters.

  • The five-year range for quarterly EV to EBITDA is 0.21 (Q3 2021) to 0.43 (Q2 2021).
  • Business Quant data shows OVID's EV to EBITDA at 0.21 (Q3 2021), 0.43 (Q2 2021) and 0.34 (Q1 2021) in the three quarters before Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Ovid Therapeutics 485.74 Mn 117.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 0.31
Sep 30, 2021 0.21
Jun 30, 2021 0.43
Mar 31, 2021 0.34
API Access

Ovid Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=OVID&period=max&api_key=YOUR_API_KEY